Difficulty: Medium
Average Score: 79%
Practice
Indicate a cholinesterase inhibitor, which has an additional direct nicotinic agonist effect:
Correct answer
C
Rationale
In this question, the correct answer is C) Neostigmine. Neostigmine is a cholinesterase inhibitor that also has an additional direct nicotinic agonist effect. This dual mechanism of action sets it apart from the other options provided.
A) Edrophonium is a short-acting cholinesterase inhibitor used for diagnostic purposes in myasthenia gravis. It does not have a direct nicotinic agonist effect.
B) Carbachol is a cholinomimetic agent that acts directly on both muscarinic and nicotinic receptors. However, it is not a cholinesterase inhibitor like neostigmine.
D) Lobeline is a nicotinic receptor agonist that acts on the autonomic ganglia and adrenal medulla but is not a cholinesterase inhibitor.
Educationally, understanding the dual mechanism of action of neostigmine is important in pharmacology, especially in the context of treating conditions like myasthenia gravis or for reversing neuromuscular blockade. Knowing the differences between cholinesterase inhibitors and direct nicotinic agonists helps in selecting the appropriate medication for specific clinical scenarios.
A) Edrophonium is a short-acting cholinesterase inhibitor used for diagnostic purposes in myasthenia gravis. It does not have a direct nicotinic agonist effect.
B) Carbachol is a cholinomimetic agent that acts directly on both muscarinic and nicotinic receptors. However, it is not a cholinesterase inhibitor like neostigmine.
D) Lobeline is a nicotinic receptor agonist that acts on the autonomic ganglia and adrenal medulla but is not a cholinesterase inhibitor.
Educationally, understanding the dual mechanism of action of neostigmine is important in pharmacology, especially in the context of treating conditions like myasthenia gravis or for reversing neuromuscular blockade. Knowing the differences between cholinesterase inhibitors and direct nicotinic agonists helps in selecting the appropriate medication for specific clinical scenarios.